How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

PR NewswireDec 23 23:49

Piper Sandler Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Cuts Target Price to $6

Futu NewsDec 16 20:34 · Ratings

Piper Sandler Sticks to Its Buy Rating for Repare Therapeutics (RPTX)

TipRanksDec 16 19:56 · Ratings

Express News | Repare Therapeutics Inc : Piper Sandler Cuts Target Price to $6 From $25

BreakingsDec 16 13:01

Analysts Offer Insights on Healthcare Companies: Repare Therapeutics (RPTX) and Centene (CNC)

TipRanksDec 15 16:10 · Ratings

Institutional Investors May Adopt Severe Steps After Repare Therapeutics Inc.'s (NASDAQ:RPTX) Latest 44% Drop Adds to a Year Losses

Simply Wall StDec 14 22:37